baber/WOPTO huggingface dataset:
Patent DK-3036183-T3 (DK)
Inventor: RÜDIGER MARTIN
IPC: B29C48/28
Filed: 2014-08-20
Granted: 2018-01-02
Abstract: The invention relates to a microduct-tube winder (5) for winding up extruded empty plastics microduct tubes having an outside diameter of about 2 to about 20 mm, having a reel (8) which is rotatable about a rotation axis (16) and has a core (9) arranged between two radially projecting flanges (10), the tube being windable on said core (9), and having a tube guiding device (6), via which the tube is fed to the reel (8), wherein a first transfer point is provided on the tube guiding device (6), the tube losing contact with the tube guiding device (6) at said first transfer point in the operating state of the microduct-tube winder (5), and wherein provision is made of a second transfer point, assigned to the reel, the tube coming into contact with the core (9) or a tube layer wound onto the latter at said second transfer point, wherein the tube guiding device (6); is movable in a transverse plane of the reel (8) and the reel (8) is movable in the direction of its rotation axis (16) such that in the operating state the winding angle (a) at the second transfer point always remains the same. The invention also relates to a double station winder (1) having two such microduct-tube winders (5), to a processing system having a microduct-tube winder (5), to a manufacturing system having an extrusion apparatus and a processing system and to a method for winding up an empty plastics tube.
Patent DK-3117490-T3 (DK)
Inventor: Lappöhn Jürgen
IPC: H01R13/645
Filed: 2015-03-09
Granted: 2018-06-25
Abstract: Reverse polarity protection for plug-in connectors comprising two intermateable plug-in connector parts (100, 200), wherein the one plug-in connector part (100) comprises a first coding element and the other plug-in connector part (200) comprises a second coding element and wherein the two coding elements are matched to each other in such a manner that when the plug-in connector parts (100, 200) are arranged correctly they make a plug-in connection possible and that when the plug-in connector parts (100, 200) are riot arranged correctly prevents a plug-in connection, characterized in that the one coding element is a groove (110) extending in the mating direction and having a trapezoid-shaped cross-section, and that the other coding element is a coding rib (210) that is extending in the mating direction and that is formed in a U-shaped manner with elastically bendable walls (212, 213)0 that are arranged in a U-shaped configuration.
Patent DK-0391274-T3 (DK)
Inventor: SASAKI YOSHIO
IPC: A61Q17/00
Filed: 1990-03-30
Granted: 1993-08-09
Abstract: A skin-protective composition which comprises an acrylic copolymer which comprises     (A) 40 to 85 % by weight of an alkyl acrylate,   (B) 5 to 50 % by weight of an alkyl methacrylate, and (C) 10 to 30 % by weight of a mono-ethylenically unsaturated monomer having a carboxyl group, and a medium, which can effectively block irritative materials and be easily removed from a skin.
Patent DK-0463224-T3 (DK)
Inventor: FOLLSTAEDT DONALD W
IPC: B22D11/06
Filed: 1990-10-04
Granted: 1996-08-12
Abstract: The continuous casting of strip (17) ribbon and wire is improved by using a free jet nozzle (27) which provides a fluid that follows a rotating substrate (19) surface to the separation point. The nozzle (27) includes an inclined surface (31) having a ratio of its length to the gap (g) between the substrate (19) and the nozzle edge of 5:1 to 15:1. The inclined surface (31) improves the ability of the jet (25) to tangentially follow the substrate (19) in a direction opposite to its rotation to the separation point. This also allows a close positioning of the nozzle (27) to the substrate (19) which serves to provide a back-up mechanical separation means by using the edge of nozzle lip. The nozzle (27) may be rotated from its operating position for cleaning of the substrate (19) and the nozzle (27). <IMAGE>
Patent DK-0396335-T3 (DK)
Inventor: BOLT IAN JAMES
IPC: A61K9/46
Filed: 1990-04-26
Granted: 1994-03-07
Abstract: A chewable tablet comprises a medicament dispersed in a chewable base, such as mannitol, together with an effervescent couple, such as citric acid - sodium bicarbonate. The combination of effervescence and chewability with optional flavourings improves the taste characteristics of the medicament in oral adminstration. A disintegrant such as microcrystalline cellulose may be added to give the patient the option of dispersing the tablet in water.
Patent DK-0431856-T3 (DK)
Inventor: HARGREAVES RODNEY BRIAN
IPC: A61P9/06
Filed: 1990-11-30
Granted: 1995-12-11
Abstract: This invention concerns novel compounds of the formula I: <CHEM> in which P is a group of formula II or a group of formula III; R<1> is alkyl, cycloalkyl, cycloalkylalkyl, phenyl or phenylalkyl; R<2> is hydrogen, alkyl, amino or alkylamino; R<3> and R<4> are independently hydrogen, alkyl, phenyl or benzyl; R<6> is alkyl, amino or alkylamino; C and D are independently ethylene or trimethylene; Z is a direct bond between C and D, or an oxy, thio, carbonyl, methylene, ethylenedioxymethylene, ethylidene, or isopropylidene link, or Z is a group of the formula = N.R<5> in which R<5> is alkyl, phenyl or benzyl; R8 is hydrogen, cycloalkylalkyl, alkyl, alkenyl, alkynyl or phenylalkyl; or R8 is a alkylene or alkenylene linked to the nitrogen atom of the group Q.A.N-, either of which linking groups may optionally bear a alkyl, phenyl or phenylalkyl substituent and either of which linking groups thereby completes a ring including two adjacent carbon atoms of ring Q, any carbon atoms in A and the adjacent nitrogen atom of the group -A.N-; A is a direct bond to the the group -N(R8)- or is alkylene; Q is a phenyl or pyridyl moiety; Y is a physiologically acceptable anion; and wherein any one or more of said phenyl, benzene or pyridyl moieties may optionally be unsubstituted or bear one or more selected substituents. The invention also includes certain closely related anhydo-base derivatives which, like the compounds of formula I, possess beneficial effects on the cardiovascular system (and in particular beneficial effects modulated via the sino-atrial node). Also included are pharmaceutical compositions containing compounds of formula I (or a related anhydro-base) as active ingrdient, and processes for the manufacrture of the various novel compounds.
Patent DK-0416069-T3 (DK)
Inventor: HEINDL JOSEF
IPC: C07C69/712
Filed: 1990-03-16
Granted: 1993-12-20
Abstract: PCT No. PCT/DE90/00209 Sec. 371 Date Nov. 19, 1990 Sec. 102(e) Date Nov. 19, 1990 PCT Filed Mar. 16, 1990 PCT Pub. No. WO90/11272 PCT Pub. Date Oct. 4, 1990.The invention relates to leukotriene-B4 derivatives of formula I,   <IMAGE> (I)  in which n=1-10, R1 means radical CH2OH, radical COOR4, radical CONHR5 or radical CONR6R7, A means a cis, trans or trans, trans-CH=CH-CH=CH group or tetramethylene group, B means an alkylene group with up to 10 C atoms, D means a direct compound, oxygen, sulfur, a -C 3BOND C group or a -CH=CR8 group, B and D together mean a direct bond, R2 means a hydrogen atom or an acid radical of an organic acid with 1-15 C atoms and R3 means a hydrogen atom, an optionally substituted alkyl radical with 1-10 C atoms, a cycloalkyl radical with 3-10 C atoms, an optionally substituted aryl radical with 6-10 C atoms or a 5-6 member heterocyclic radical and if R4 means a hydrogen atom, their salts with physiologically compatible bases and their cyclodextrin clathrates, process for their production and their pharmaceutical use.
Patent DK-0449780-T3 (DK)
Inventor: FISCHER MORITZ
IPC: B66B23/12
Filed: 1991-03-22
Granted: 1996-10-14
Abstract: So that a reliable connection between marginal strips (3), inserted into the step plate (2) of a step element, and the step plate (2) can be produced in a simple manner by the diecasting process, the marginal strips (3) each have a tongue (6, 7) on their underside at least along their two longitudinal edges. The cross-sections of the two tongues (6, 7) have the shape of a parallelogram with angles identical to one another or of a trapezium and engage like a tongue-and-groove joint in corresponding grooves (8, 9) in the step plate (2). Furthermore, these marginal strips (3) are also provided on their underside with at least two integrally cast locking pins (10) extending downwards and through the adjoining step plate (2). One clamping ring (11) each, supported in a flexible manner on the underside of the step plate 2, is firmly clamped to the free ends of the locking pins (10), which free ends project downwards out of the step plate (2). 
<IMAGE>
Patent DK-0569356-T3 (DK)
Inventor: ANDERSSON SVEN B
IPC: A24B15/28
Filed: 1991-06-03
Granted: 1998-04-06
Abstract: PCT No. PCT/SE91/00385 Sec. 371 Date Dec. 8, 1992 Sec. 102(e) Date Dec. 8, 1992 PCT Filed Jun. 3, 1991 PCT Pub. No. WO91/18525 PCT Pub. Date Dec. 12, 1991.The invention is comprised of a smoking composition of nicotine in the form of an inclusion complex located between crylisized polysaccharide and nicotine and a smoking material. The composition releases nicotine when exposed to elevated temperatures.
Patent DK-0578847-T3 (DK)
Inventor: HAMANAKA NOBUYUKI
IPC: C07D213/30
Filed: 1992-07-14
Granted: 1997-03-17
Abstract: A fused benzeneoxyacetic acid derivative of the formula: <CHEM>  wherein <CHEM>  is     (i) <CHEM>     (ii) <CHEM>     (iii) <CHEM>  or   (iv) <CHEM>       A is     (i) <CHEM>  or   (ii)   <CHEM>   R<1> is   hydrogen or C1-4 alkyl; R<2> is   hydrogen, C1-6 alkyl or phenyl; R<3> is     (i) C1-15 alkyl, (ii) C1-8 alkyl substituted by one or two of benzene, C4-7 cycloalkane or 4-7 ring-membered monocyclic ring which contains one nitrogen atom or   (iii) C10-15 condensed tricyclic ring;   e is   3-5; f is   1-3; p is   0-4; q is   0-2; s is   0-3 With the proviso that, ring(s) in R<3> may be substituted by one to three of C1-4 alkyl, 1-4 alkoxy, halogen atom, nitro or trihalomethyl. And, when D -- B is the formula (iii) or (iv), -(CH2)p- or =CH-(CH2)s- is attached at the position of a or b on the ring. and non-toxic salts thereof possess an antagonistic activity on PGI2 receptor, so it is useful for prevention and/or treatment of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer and hypertension.
Patent DK-0536654-T3 (DK)
Inventor: VIESSMANN HANS DR
IPC: F24H9/12
Filed: 1992-10-02
Granted: 1996-04-01
Abstract: The invention relates to an accumulator with a double shell for preparing and storing hot domestic water, consisting of a storage container (1) which is provided with cold water supply and hot water outlet connections (3, 4) and which, apart from the container bottom (5) provided with the connections (3, 4), is surrounded at a short distance with a shape-matched outer shell (2) which conducts the heating medium and on which the heating medium forward and return run connections (6, 7) are arranged. According to the invention, of the forward and return run connections (6, 7) connected to openings (14) at the upper end of the outer shell (2), at least the forward run connection (6) has with its longitudinal axis (LA), which is axially parallel to the longitudinal axis (BA) of the container, a distance (D) from the wall (W) of the outer shell (2) which is at most slightly greater than half the diameter of the outflow opening (A) of the connection (6). <IMAGE>
Patent DK-0528474-T3 (DK)
Inventor: GOMMERS NORBERTUS ADRIANUS J
IPC: E04B9/06
Filed: 1992-07-29
Granted: 1996-11-11
Abstract: The invention provides a ceiling system for instance for a lowered filter ceiling (1) consisting of flat profile pieces (3) supporting filter parts, coupling pieces (4) connecting the profile pieces (4) in airtight manner, suspending means connectable to the profile pieces and/or the coupling pieces, and locking means for locking the coupling piece (4) and the profile piece (3) relative to one another, wherein the locking means take the form of a locking pin (20) engaging in a substantially cylindrical open channel (13) and provided on its periphery with a sealing ring (21), and the coupling piece (4) has a portion (5) complementing the open channel and that in this complementing portion a passage (28) is provided for a screw bolt (26) engaging in the locking pin (20). The profile pieces (3) are substantially U-shaped, and the likewise substantially U-shaped coupling pieces (4) have portions which can be arranged clampingly between the legs of the profile pieces in close-fitting manner and which are preferably received in the profile pieces (3) with interposing of a sealing element (19). The system is easy to assemble, comprises a limited number of components that are simple to manufacture and is easily adaptable to the situation prevailing at a particular place. The use of an O-ring (21) results in a certain sealing, whereby air leakages are substantially excluded. <IMAGE>
Patent DK-0501725-T3 (DK)
Inventor: JEFFERIES ANDREW
IPC: B05B11/04
Filed: 1992-02-24
Granted: 2001-10-01
Abstract: Relatively low resistivity liquids are formed into sprays under the influence of an applied electric field acting between a nozzle 10 and the surroundings (e.g. at earth potential. The liquid issues from the nozzle as a ligament which is caused to undergo necking to a smaller diameter than that of the nozzle orifice 14, thereby producing droplets with a volume median diameter less than the orifice diameter.  <IMAGE>
Patent DK-0527063-T3 (DK)
Inventor: HOUDEBINE LOUIS-MARIE
IPC: C07K14/52
Filed: 1992-06-12
Granted: 2003-12-22
Abstract: The present invention relates to a process for the preparation of a heterologous protein of interest in the mature form or in the fused form from the milk of mammalian female, a process in which:     - the said female is bred and, - the milk is recovered from which the said protein is recovered and separated if necessary, characterised in that the said female is a transgenic animal into whose genome a sequence encoding the said protein of interest has been integrated under the control of at least one sequence which is among the elements for the expression of rabbit WAP protein and which is present in the fragment which is at least 3 Kb in length from the 3% end of the complete WAP promoter. It also relates to the milk product obtained and to an eukaryotic cell which has integrated the sequences described.
Patent DK-0602478-T3 (DK)
Inventor: KAMIYA TAKASHI
IPC: A61K31/7042
Filed: 1993-12-03
Granted: 1996-09-30
Abstract: A novel process for producing N<4>-acyl-5'-deoxy-5-fluorocytidine derivatives using the novel 5'-deoxy-5-fluoro-N<4>,2'-O,3'-O-triacylcytidine derivatives are provided. 5-Deoxy-1,2,3-tri-O-acyl- beta -D-ribofuranoside is reacted with 5-fluorocytosine to produce 5'-deoxy-2',3'-di-O-acyl-5-fluorocytidine, followed by acylation. The acyl radicals of the obtained 5'-deoxy-5-fluoro-N<4>,2'-O,3'-O-triacylcytidine derivatives are selectively de-O-acylated to obtain N<4>-acyl-5'-deoxy-5-fluorocytidine derivatives. From fluorocytosine, N<4>-acyl-5'-deoxy-5-fluorocytidine derivatives can be obtained through very few steps in high yield.
Patent DK-0580547-T3 (DK)
Inventor: KOPP VOLKER
IPC: B01F5/04
Filed: 1993-05-28
Granted: 1996-11-04
Abstract: For injection devices for two-component materials, a nozzle is provided within which the mixing of the individual components takes place. The nozzle has a mixing tube (1) for a first discharge opening (3a) and, arranged coaxially therewith, a tube piece (2) for a second discharge opening (3b) of the injection device. The pipe piece (2) is provided with a non-return valve which comprises passages (2b) of the pipe piece (2) and a sleeve (5) surrounding this region of the pipe piece (2). This non-return valve prevents a back-surge of the individual components and promotes the formation of a closure by a portion of cured components, so that even during actuation of the injection device with the nozzle, with cured components accumulated thereon, still mounted, no back-surge into the injection device occurs. <IMAGE>
Patent DK-0656098-T3 (DK)
Inventor: HODGE STEVE
IPC: F03C2/08
Filed: 1993-08-09
Granted: 1997-12-29
Abstract: PCT No. PCT/GB93/01680 Sec. 371 Date Jan. 24, 1995 Sec. 102(e) Date Jan. 24, 1995 PCT Filed Aug. 9, 1993 PCT Pub. No. WO94/04824 PCT Pub. Date Mar. 3, 1994A compact gerotor pump having reduced axial dimension has an external fixed pump body in which a rotor and annulus set is housed. A drive shaft is provided that is neither fixed nor journalled directly by the pump body. The shaft is secured to the rotor within the body and extends through an opening in an end wall of the body and is secured to the hub of an external drive gear that is journalled by the housing for driven rotation of the drive gear, shaft, and rotor relative to the pump body.
Patent DK-0719267-T3 (DK)
Inventor: MICHNICK JOHN
IPC: A61P37/06
Filed: 1994-03-31
Granted: 2002-11-25
Abstract: The invention provides a group of compounds that are effective agents to inhibit specific cellular signaling events often induced by inflammatory stimuli, to act as anti-inflammatory or immunosuppressive agents, to act as cytotoxic agents for treatment of cancers, or to be directly or indirectly antimicrobial to yeast or fungal infections. More specifically, the inventive compounds have at least one amino alcohol (or derivative thereof) functional group on a side chain attached to a core moiety. The inventive compounds are useful antagonists to control intracellular levels of specific sn-2 unsaturated phosphatidic acids and corresponding phosphatidic acid-derived diacylglycerols, intracellular cell signaling messengers which occur in response to pro-inflammatory and selectively proliferative stimuli.
Patent DK-0717638-T3 (DK)
Inventor: JOSEPH PH D RUBINFELD
IPC: A61K47/40
Filed: 1994-09-02
Granted: 2002-07-01
Abstract: Compositions of matter comprising a substituted cyclodextrin and cytotoxic compound, especially cytotoxic drugs such as antibiotic, anti-fungal and anti-neoplastic, drugs are claimed. The compositions cause significantly less ulceration compared to the same formulation of cytotoxic compound without cyclodextrin compound when extravasated. The compositions may also cause less vascular irritation compared to the same formulation of cytotoxic compound without cyclodextrin when administered intravenously without extravasation. Compositions of matter comprising watersoluble cytotoxic agents, especially anticancer drugs and anti-ulceration effective or anti-irritatioin effective amounts of cyclodextrin compounds are also claimed. Methods for reducing the likelihood of ulceration and or irritation when administering the compositions according to the invention are also disclosed and claimed.
Patent DK-0688909-T3 (DK)
Inventor: HEIMANN BRUNO
IPC: E03C1/05
Filed: 1995-05-29
Granted: 1999-09-27
Abstract: An electrically controlled water outlet fitting has a main body (120 that receives and insert (11) that has a rotary mixing valve (4) that varies the amount of hot and cold water supplied from inlet, pipes (113). The insert has a recess that receives an electronic module (2). This is battery (22) powered and is removed by releasing a screw (3). The cover is removed to replace the battery, the valve is adjusted by the operation of an electromagnetic actuator (32). <IMAGE>
Patent DK-0706014-T3 (DK)
Inventor: CULZONI MARCO
IPC: F28F19/00
Filed: 1995-07-25
Granted: 2000-01-03
Abstract: Has two heat shield sheets (2) suspended within the combustion chamber which has a cover (14) and side walls (12) next to each other. The heat shields are not in connection with the walling of the combustion chamber, so that when heating occurs they are free to expand sideways. One of the heat protection shields has five apertures (22), through which the free ends of the heat exchanger tubes and of the connecting tubes for the heat exchanger tubes are insertable. Between the individual apertures within the heat protection shields dividing sheets (24) are provided, formed as tangents to the circular apertures.
Patent DK-0709383-T3 (DK)
Inventor: WIERZBICKI MICHEL
IPC: A61P29/00
Filed: 1995-10-25
Granted: 2000-04-25
Abstract: Diosmetin derivs. of formula (I) and their diastereomers and/or enantiomers are new. R1 = H, propyl, allyl or 1,2-dideuteroallyl; R2 = H, propyl, allyl, propargyl, 2,3-dihydroxypropyl, (2,2-dimethyl- 1,3-dioxol-4-yl) methyl or 3-acetyloxy-2-hydroxypropyl; R3 = H, propyl, allyl or 1,2-dideuteroallyl; R4 = H, Me, propyl, allyl, propargyl, 2,3-dihydroxypropyl, (2,2-dimethyl- 1,3-dioxol-4-yl)methyl or COR4'; R5 = H, propyl, allyl or 1,2-dideuteroallyl; and R6 = H, Me, propyl, allyl, propargyl, 2,3-dihydroxypropyl, (2,2-dimethyl- 1,3-dioxol-4-yl)methyl, COR6' or a gp. of formula (i); R4', R6' = 1-5C alkyl or Ph; provided that at least one of R1-R6 is other than H; and if R1- R3 = H, then R4 = H.
Patent DK-0729350-T3 (DK)
Inventor: NEW ROGER RANDAL CHARLES
IPC: C12N9/00
Filed: 1994-11-14
Granted: 2001-06-18
Abstract: Single phase preparations of hydrophilic species, in particular macromolecular compounds such as proteins or glycoproteins in a hydrophobic solvent such as an oil can be obtained by preparing a hydrophile/amphiphile array in which the hydrophilic head groups of the amphiphile are orientated towards the hydrophilic species and bringing the array into contact with the hydrophobic solvent. The preparations of the invention can be used alone or can be combined with an aqueous phase to form emulsions in which the hydrophilic species is present in the hydrophobic phase. The compositions of the present invention are versatile and have application in the pharmaceutical, food, cosmetic, chemical and agricultural industries.
Patent DK-0752877-T3 (DK)
Inventor: FJELLESTAD-PAULSEN ANNE
IPC: A61K38/095
Filed: 1995-03-09
Granted: 2000-10-16
Abstract: PCT No. PCT/SE95/00249 Sec. 371 Date Oct. 23, 1996 Sec. 102(e) Date Oct. 23, 1996 PCT Filed Mar. 9, 1995 PCT Pub. No. WO95/25534 PCT Pub. Date Sep. 28, 1995A solid pharmaceutical composition for oral administration of small and medium size peptides, particularly vasopressin, oxytocin, and their analogues, comprises said peptide, an enteric coat and a pharmaceutically acceptable carrier containing a buffering agent buffering at a pH of from 2 to 6, preferably at about pH 5. A method of manufacture of single doses of said peptide comprises mixing of the ingredients, forming the resulting mixture into spheres smaller than 2 mm, coating the spheres with an enteric coat which is readily soluble in gastric juice of pH 5.0 or higher but not at substantially lower pH, and filling the coated spheres in capsules or incorporating them into tablets, degradable in the stomach. Also disclosed is a method for oral administration to a patient of said single dose.
Patent DK-0768429-T3 (DK)
Inventor: MUELLER HARALD
IPC: E01B26/00
Filed: 1996-10-09
Granted: 2001-12-10
Abstract: The safety barrier has a holding bar (1) with a projecting support (5) for a barrier, in order to protect a rail section (3) on a track, and has equipment (4) to form a detachable fastening with the rail. The bar has a retaining region (6), which grips around the profile of the rail against the force of an elastic spring element (7). The element is in the form of a helical compression spring (17), which is supported against an abutment which limits the maximum possible travel of the retaining region in the direction of a retaining stop (9). The abutment is attached to a profile component (15) on the fixed retaining stop at a place which at a distance from the stop part (13).